Overview

A Study of MTP-131 Topical Ophthalmic Solution in Subjects With Diabetic Macular Edema and Non-Exudative Intermediate Age-related Macular Degeneration

Status:
Completed

Trial end date:
2015-06-01

Target enrollment:

Participant gender:

Summary

This is a Phase 1/2, open-label, dose-escalation clinical study, enrolling 21 subjects in one of the two treatment groups to determine the effects of topical ocular administration of low dose or high dose MTP-131 given twice a day in subjects with Diabetic Macular Edema and Age-Related Macular Degeneration.

Phase:

Phase 1/Phase 2

Details

Lead Sponsor:

Stealth BioTherapeutics Inc.

Treatments:

Ophthalmic Solutions
Pharmaceutical Solutions